Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


01.04.2019

1 Acta Cytol
2 Ann Oncol
4 BMC Cancer
1 Breast Cancer Res
2 Breast Cancer Res Treat
3 Breast J
2 Cancer Lett
1 Cancer Res
2 Clin Breast Cancer
1 Clin Cancer Res
1 Curr Treat Options Oncol
3 Eur J Surg Oncol
1 Exp Cell Res
1 Gene
1 Int J Cancer
1 J Clin Oncol
1 Lancet Oncol
1 N Engl J Med
1 PLoS Comput Biol
3 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. KUMAR PV, Mokhtari M
    Cytological Findings in Benign Phyllodes Tumors.
    Acta Cytol. 2019;63:23-27.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. MESSAOUDENE M, Mourikis TP, Michels J, Fu Y, et al
    T cell Bispecific Antibodies in Node-Positive Breast Cancer: Novel Therapeutic Avenue for MHC class I Loss Variants.
    Ann Oncol. 2019 Mar 29. pii: 5423181. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. VEERARAGHAVAN J, De Angelis C, Mao R, Wang T, et al
    A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.
    Ann Oncol. 2019 Mar 23. pii: 5418530. doi: 10.1093.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. CAPERCHIONE CM, Sabiston CM, Stolp S, Bottorff JL, et al
    A preliminary trial examining a 'real world' approach for increasing physical activity among breast cancer survivors: findings from project MOVE.
    BMC Cancer. 2019;19:272.
    PubMed     Text format     Abstract available

  5. SSEMMANDA S, Katagirya E, Bukirwa P, Alele D, et al
    Breast diseases histologically diagnosed at a tertiary facility in Uganda (2005-2014).
    BMC Cancer. 2018;18:1285.
    PubMed     Text format     Abstract available

  6. HICKS DG, Buscaglia B, Goda H, McMahon L, et al
    A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study.
    BMC Cancer. 2018;18:1266.
    PubMed     Text format     Abstract available

  7. ANNUNZIATA MA, Muzzatti B, Bomben F, Flaiban C, et al
    A contribution to the validation of the Italian version of the Body Image Scale (BIS).
    BMC Cancer. 2018;18:1222.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  8. FALSTIE-JENSEN AM, Kjaersgaard A, Lorenzen EL, Jensen JD, et al
    Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.
    Breast Cancer Res. 2019;21:44.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  9. DANIELL KM, Bardia A, Sun F, Roberts SA, et al
    Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer.
    Breast Cancer Res Treat. 2019 Mar 27. pii: 10.1007/s10549-019-05206.
    PubMed     Text format     Abstract available

  10. AURIT SJ, Devesa SS, Soliman AS, Schairer C, et al
    Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
    Breast Cancer Res Treat. 2019 Mar 26. pii: 10.1007/s10549-019-05193.
    PubMed     Text format     Abstract available


    Breast J

  11. ARENA V, Pennacchia I, Vecchio FM, Carbone A, et al
    ER-/PR+/HER2- breast cancer type shows the highest proliferative activity among all other combined phenotypes and is more common in young patients: Experience with 6643 breast cancer cases.
    Breast J. 2019 Mar 27. doi: 10.1111/tbj.13236.
    PubMed     Text format     Abstract available

  12. GABANI P, Weiner AA, Hernandez-Aya LF, Khwaja S, et al
    Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model.
    Breast J. 2019 Mar 28. doi: 10.1111/tbj.13230.
    PubMed     Text format     Abstract available

  13. KOZAK MM, Xiang M, Pollom EL, Horst KC, et al
    Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis.
    Breast J. 2019 Mar 29. doi: 10.1111/tbj.13251.
    PubMed     Text format     Abstract available


    Cancer Lett

  14. LIM JP, Nair S, Shyamasundar S, Chua PJ, et al
    Silencing Y-box binding protein-1 inhibits triple-negative breast cancer cell invasiveness via regulation of MMP1 and beta-catenin expression.
    Cancer Lett. 2019 Mar 21. pii: S0304-3835(19)30170.
    PubMed     Text format     Abstract available

  15. GUO L, Cheng X, Chen H, Chen C, et al
    Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis.
    Cancer Lett. 2019 Mar 24. pii: S0304-3835(19)30188.
    PubMed     Text format     Abstract available


    Cancer Res

  16. YIN T, Zhao ZB, Guo J, Wang T, et al
    Aurora-A inhibition eliminates myeloid cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in breast cancer.
    Cancer Res. 2019 Mar 22. pii: 0008-5472.CAN-18-3397.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  17. NATSIOPOULOS I, Intzes S, Liappis T, Zarampoukas K, et al
    Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30845.
    PubMed     Text format     Abstract available

  18. WOODWARD N, De Boer RH, Redfern A, White M, et al
    Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE).
    Clin Breast Cancer. 2019 Feb 27. pii: S1526-8209(18)30696.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  19. KRAYA AA, Maxwell KN, Wubbenhorst B, Wenz BM, et al
    Genomic signatures predict the immunogenicity of BRCA-deficient breast cancer.
    Clin Cancer Res. 2019 Mar 26. pii: 1078-0432.CCR-18-0468.
    PubMed     Text format     Abstract available


    Curr Treat Options Oncol

  20. FORCE J, Leal JHS, McArthur HL
    Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading.
    Curr Treat Options Oncol. 2019;20:35.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  21. SUTINEN M, Kontunen A, Karjalainen M, Kiiski J, et al
    Identification of breast tumors from diathermy smoke by differential ion mobility spectrometry.
    Eur J Surg Oncol. 2019;45:141-146.
    PubMed     Text format     Abstract available

  22. KELEMEN P, Pukancsik D, Ujhelyi M, Savolt A, et al
    Comparison of clinicopathologic, cosmetic and quality of life outcomes in 700 oncoplastic and conventional breast-conserving surgery cases: A single-centre retrospective study.
    Eur J Surg Oncol. 2019;45:118-124.
    PubMed     Text format     Abstract available

  23. KIM I, Choi HJ, Ryu JM, Lee SK, et al
    A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning.
    Eur J Surg Oncol. 2019;45:134-140.
    PubMed     Text format     Abstract available


    Exp Cell Res

  24. LI D, Wang X, Yang M, Kan Q, et al
    miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint.
    Exp Cell Res. 2019 Mar 20. pii: S0014-4827(19)30126.
    PubMed     Text format     Abstract available


    Gene

  25. SAFARI MR, Rezaei FM, Dehghan A, Noroozi R, et al
    Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population.
    Gene. 2019 Mar 22. pii: S0378-1119(19)30293-8. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


    Int J Cancer

  26. CHENG I, Tseng C, Wu J, Yang J, et al
    Association between ambient air pollution and breast cancer risk: The Multiethnic Cohort Study.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32308.
    PubMed     Text format     Abstract available


    J Clin Oncol

  27. CHANDARLAPATY S, Razavi P
    Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 Inhibitors.
    J Clin Oncol. 2019 Mar 28:JCO1900090. doi: 10.1200/JCO.19.00090.
    PubMed     Text format    


    Lancet Oncol

  28. STIRRUPS R
    Neratinib and capecitabine for breast cancer brain metastases.
    Lancet Oncol. 2019 Mar 22. pii: S1470-2045(19)30184.
    PubMed     Text format    


    N Engl J Med

  29. MEHTA RS, Barlow WE, Albain KS, Vandenberg TA, et al
    Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
    N Engl J Med. 2019;380:1226-1234.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  30. DAMIANI C, Maspero D, Di Filippo M, Colombo R, et al
    Integration of single-cell RNA-seq data into population models to characterize cancer metabolism.
    PLoS Comput Biol. 2019;15:e1006733.
    PubMed     Text format     Abstract available


    PLoS One

  31. JIANG Y, Chen L, Zhang H, Xiao X, et al
    Breast cancer histopathological image classification using convolutional neural networks with small SE-ResNet module.
    PLoS One. 2019;14:e0214587.
    PubMed     Text format     Abstract available

  32. WITTKOWSKI KM, Dadurian C, Seybold MP, Kim HS, et al
    Correction: Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer.
    PLoS One. 2019;14:e0214826.
    PubMed     Text format     Abstract available

  33. ZITO P, Labbozzetta M, Notarbartolo M, Sajeva M, et al
    Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells.
    PLoS One. 2019;14:e0214594.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  34. ZHANG J, Goliwas KF, Wang W, Taufalele PV, et al
    Energetic regulation of coordinated leader-follower dynamics during collective invasion of breast cancer cells.
    Proc Natl Acad Sci U S A. 2019 Mar 28. pii: 1809964116.
    PubMed     Text format     Abstract available

  35. KROGER C, Afeyan A, Mraz J, Eaton EN, et al
    Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
    Proc Natl Acad Sci U S A. 2019 Mar 25. pii: 1812876116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: